AKR1C3 and cancer: Aldo-keto reductase 1C3 (AKR1C3) is known to be a cancer biomarker correlated to androgen synthesis, and causes drug resistance by direct action on chemotherapeutics and by stabilizing AR splice variant 7 (ARv7).